![Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7013e3_COVIDVaccineFieldEffectiveness_IMAGE_29Mar21_v2_1200x627.jpg?_=23735)
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December
![Moderna on X: "5 Phase 1 studies ongoing; 7 add'l dev programs advancing toward clinic, incl novel #mRNA #vaccines & #mRNA #ImmunoOncology therapeutics https://t.co/IECjtS1XzQ" / X Moderna on X: "5 Phase 1 studies ongoing; 7 add'l dev programs advancing toward clinic, incl novel #mRNA #vaccines & #mRNA #ImmunoOncology therapeutics https://t.co/IECjtS1XzQ" / X](https://pbs.twimg.com/media/C-b6aASW0AAXaGI.jpg)
Moderna on X: "5 Phase 1 studies ongoing; 7 add'l dev programs advancing toward clinic, incl novel #mRNA #vaccines & #mRNA #ImmunoOncology therapeutics https://t.co/IECjtS1XzQ" / X
![Moderna on X: "So proud of the progress our team is making on behalf of patients. Filed an IND for our 10th #mRNA medicine in less than two years! https://t.co/7vFgPFP5vq" / X Moderna on X: "So proud of the progress our team is making on behalf of patients. Filed an IND for our 10th #mRNA medicine in less than two years! https://t.co/7vFgPFP5vq" / X](https://pbs.twimg.com/media/DMYRLgsU8AEATgH.jpg:large)
Moderna on X: "So proud of the progress our team is making on behalf of patients. Filed an IND for our 10th #mRNA medicine in less than two years! https://t.co/7vFgPFP5vq" / X
![Vaccines | Free Full-Text | Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response Vaccines | Free Full-Text | Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response](https://www.mdpi.com/vaccines/vaccines-10-00585/article_deploy/html/images/vaccines-10-00585-g001.png)
Vaccines | Free Full-Text | Impact of Moderna mRNA-1273 Booster Vaccine on Fully Vaccinated High-Risk Chronic Dialysis Patients after Loss of Humoral Response
![Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine — United States, December 21, 2020–January 10, 2021 | MMWR Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine — United States, December 21, 2020–January 10, 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/figures/mm7004e1-F.gif)
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Moderna COVID-19 Vaccine — United States, December 21, 2020–January 10, 2021 | MMWR
![The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19 The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7111a4_ACIPModernaCOVID19_IMAGE_18March2022_1200x675.jpg?_=33448)
The Advisory Committee on Immunization Practices' Recommendation for Use of Moderna COVID-19 Vaccine in Adults Aged ≥18 Years and Considerations for Extended Intervals for Administration of Primary Series Doses of mRNA COVID-19
![Pfizer and Moderna Are Pushing the New Covid Booster. Should You Get It? The CDC Is About to Decide. - KFF Health News Pfizer and Moderna Are Pushing the New Covid Booster. Should You Get It? The CDC Is About to Decide. - KFF Health News](https://kffhealthnews.org/wp-content/uploads/sites/2/2023/09/GettyImages-1372188531.jpg)
Pfizer and Moderna Are Pushing the New Covid Booster. Should You Get It? The CDC Is About to Decide. - KFF Health News
Rolando Pajon, PhD on LinkedIn: U.S. FDA Authorizes Two COVID Boosters Targeted at Omicron Subvariants
![Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 | MMWR Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7018e1_EffectivenessOlderAdults_IMAGE_28Apr21_1200x627.jpg?_=40683)
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021 | MMWR
![Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel — 33 U.S. Sites, January–March 2021 | MMWR](https://www.cdc.gov/mmwr/volumes/70/wr/social-media/mm7020e2_EffectivenessPfizerModernaHCP_IMAGE_14May21_1200x627.jpg?_=36679)